Work

Gemcitabine, Ifosfamide, Oxaliplatin and Rituximab (R-GIFOX), a New Effective Cytoreductive/Mobilizing Salvage Regimen for Relapsed and Refractory Aggressive Non-Hodgkin’s Lymphoma: Results of a Pilot Study.

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.940.940

Authors: Gaetano Corazzelli, Filippo Russo, Gaetana Capobianco, Gianpaolo Marcacci, Paola Della Cioppa, Antonio Pinto

Institution: Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587812940

FWCI: 0.493

Cites:

Cited by: 3

Related to: 10